Evidence map›Paper›PMID 23436224›Full record

ArticleEuropean journal of immunology2013

Diversification and senescence of Foxp3+ regulatory T cells during experimental autoimmune encephalomyelitis.

Sharyn Tauro, Phuong Nguyen, Bofeng Li, Terrence L Geiger

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. The role of KLRG1: a novel biomarker and new therapeutic target.Cell communication and signaling : CCS · 2024
    Review
  3. The Yin and Yang of Targeting KLRG1Frontiers in immunology · 2022
    Review
  4. CD4Frontiers in pediatrics · 2019
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sharyn TauroDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Phuong Nguyen
Bofeng Li
Terrence L Geiger
St. Jude Children's Research Hospital · US

Funding

TREATMENT OF AUTOIMMUNITY WITH REGULATORY T LYMPHOCYTESR01AI056153 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GEIGER, TERRENCE L · 2004 to 2013
$3.9M
NIAID NIH HHS R01 AI056153
6 · The paper itself

Abstract

The fate of Foxp3(+) regulatory T (Treg) cells responding during autoimmunity is not well defined. We observed a marked elevation in KLRG1(+) (where KLRG1 stands for killer cell lectin-like receptor G1) CNS-infiltrating Treg cells in experimental autoimmune encephalomyelitis (EAE), and assessed their origin and properties. KLRG1(+) Treg cells showed increased activation marker expression, Foxp3 and CD25 levels, and more rapid cell cycling than KLRG1(-) cells. KLRG1(-) Treg cells converted into KLRG1(+) cells and this was increased in autoimmune inflammation. Conversion was unidirectional; KLRG1(+) Treg cells did not revert to a KLRG1(-) state. KLRG1(+) but notKLRG1(-) Treg cells survived poorly, indicative of terminal differentiation. This was associated with diminished BCL2 and increased apoptosis of isolated cells. KLRG1 was also upregulated on iTreg cells after transfer and EAE induction or on iTreg cells developing spontaneously during EAE. KLRG1(+) Treg cells produced more IL-10 and had altered effector cytokine production compared with their KLRG1(-) counterparts. Despite their differences, KLRG1(+) and KLRG1(-) Treg cells proved similarly potent in suppressing EAE. KLRG1(+) and KLRG1(-) populations were phenotypically heterogeneous, with the extent and pattern of activation marker expression dependent both on cellular location and inflammation. Our results support an extensive diversification of Treg cells during EAE, and associate KLRG1 with altered Treg-cell function and senescence.

Indexed as

Adoptive TransferAnimalsApoptosisAutoimmunityCell DifferentiationCellular SenescenceEncephalomyelitis, Autoimmune, ExperimentalForkhead Transcription FactorsGene ExpressionImmunophenotypingInterleukin-10Interleukin-2 Receptor alpha SubunitLectins, C-TypeMiceMice, KnockoutProto-Oncogene Proteins c-bcl-2Forkhead Transcription FactorsFoxp3 protein, mouseIL10 protein, mouseInterleukin-10Interleukin-2 Receptor alpha SubunitKlrg1 protein, mouseLectins, C-TypeProto-Oncogene Proteins c-bcl-2Receptors, Immunologic

Identifiers

PMID23436224
PMCPMC3775602
OpenAlexW1882796581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.